---
created: '2026-02-08T19:29:31.576372Z'
description: Tumor Necrosis Factor Alpha is a pro-inflammatory cytokine produced primarily
  by activated macrophages, playing a central role in systemic inflammation and immune
  cell regulation.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/biomarker/tnf-alpha/
slug: tnf-alpha
tags:
- biomarker
title: TNF Alpha
type: biomarker
updated: '2026-02-08T19:29:31.576372Z'
---

# TNF Alpha

## Overview
Tumor Necrosis Factor Alpha (TNF-alpha) is a potent pro-inflammatory cytokine primarily produced by activated macrophages, though it is also secreted by monocytes, T lymphocytes, natural killer cells, and adipocytes. It is a master regulator of the inflammatory cascade, capable of inducing fever, apoptosis, cachexia, and the production of other pro-inflammatory cytokines including IL-1, IL-6, and IL-8.

TNF-alpha signals through two receptors: TNFR1 (expressed on most tissues, mediates apoptosis and inflammation) and TNFR2 (primarily on immune cells, mediates cell survival and proliferation). Dysregulated TNF-alpha production is a key driver of chronic inflammatory and autoimmune diseases, including rheumatoid arthritis, inflammatory bowel disease (Crohn's disease and ulcerative colitis), psoriasis, and ankylosing spondylitis.

The clinical importance of TNF-alpha is underscored by the success of anti-TNF biological therapies (infliximab, adalimumab, etanercept), which are among the most prescribed biologics worldwide. Measuring circulating TNF-alpha levels can help assess inflammatory burden, though levels are highly variable and must be interpreted in clinical context.

## Reference Ranges

| Range | Value | Interpretation |
|-------|-------|----------------|
| **Low** | <1.0 pg/mL | Minimal TNF-alpha activity |
| **Normal** | <8.1 pg/mL | No significant systemic TNF-alpha elevation |
| **High** | >8.1 pg/mL | Active inflammatory or autoimmune process |
| **Optimal** | <4.0 pg/mL | Low inflammatory burden |

## Testing Information
- **Measurement Unit**: pg/mL
- **Sample Type**: Serum
- **Fasting Required**: False
- **Recommended Test Frequency**: As needed; useful for monitoring autoimmune disease activity and response to anti-TNF therapy

## ðŸ’Š Supplements That Affect This Biomarker

- [[Curcumin]] - Decreases TNF-alpha by inhibiting NF-kB and MAPK signaling (moderate, evidence level 3)
- [[Omega-3 Fatty Acids]] - Decreases TNF-alpha production through EPA/DHA-mediated anti-inflammatory pathways (moderate, evidence level 3)
- [[Resveratrol]] - Decreases TNF-alpha in metabolic syndrome through SIRT1 activation and NF-kB suppression (mild, evidence level 3)

## ðŸ§ª Lab Tests That Measure This Biomarker

### Direct Tests
- [[tnf alpha]] - TNF-alpha immunoassay (ELISA or multiplex cytokine panel)

### Panel Tests
- [[advanced inflammation panel]] (labtestpanel) - Includes TNF-alpha in comprehensive cytokine assessment

## Relationships

### Activates
- â†’ [[Interleukin 6]] (biomarker)
- â†’ [[Hs Crp]] (biomarker)

### Correlations
- â†’ [[Interleukin 6]] (biomarker) - TNF-alpha stimulates IL-6 production; both are elevated in systemic inflammation
- â†’ [[Hs Crp]] (biomarker) - TNF-alpha indirectly elevates CRP through IL-6 stimulation of hepatic CRP synthesis

## References
- PMID:31799018 - White CM et al. Oral curcumin as an adjunctive therapy for inflammatory conditions. Pharmacotherapy. 2019.
- PMID:27392742 - Sahebkar A et al. Effect of curcuminoids on oxidative stress and inflammatory markers. Crit Rev Food Sci Nutr. 2016.
- PMID:22317966 - Li K et al. Effect of marine-derived n-3 polyunsaturated fatty acids on inflammatory markers. PLoS One. 2014.
- PMID:29210129 - Haghighatdoost F et al. Effect of resveratrol on metabolic syndrome components. Ann N Y Acad Sci. 2018.

## Dataview Queries
```dataview
LIST
FROM [[TNF Alpha]]
WHERE contains(type, "Intervention")
SORT confidence_score DESC
```